Caitong International Asset Management Co., LTD Biotechnology

Caitong International Asset Management Co., LTD

$102 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VKTX Viking Therapeutics, Inc.	$2.26B	$331 Million 0.32% of portfolio	8,219	Q4 2024 New
GERN Geron Corp	$960M	$208 Million 0.2% of portfolio	58,863	Q4 2024 New
ACAD Acadia Pharmaceuticals Inc	$3.18B	$179 Million 0.18% of portfolio	9,751	Q4 2024 New
IOVA Iovance Biotherapeutics, Inc.	$892M	$179 Million 0.17% of portfolio	24,131	Q4 2024 New
NTLA Intellia Therapeutics, Inc.	$933M	$177 Million 0.17% of portfolio	15,216	Q4 2024 New
ALT Altimmune, Inc.	$332M	$175 Million 0.17% of portfolio	24,336	Q4 2024 New
SNDX Syndax Pharmaceuticals Inc	$834M	$116 Million 0.11% of portfolio	8,762	Q4 2024 New
NVAX Novavax Inc	$627M	$116 Million 0.11% of portfolio	14,376	Q4 2024 New
RNA Avidity Biosciences, Inc.	$1.66B	$115 Million 0.11% of portfolio	3,939	Q4 2024 New
CRSP Crispr Therapeutics Ag	$3.93B	$97.4 Million 0.1% of portfolio	2,475	Q4 2024 New
ARQT Arcutis Biotherapeutics, Inc.	$782M	$96.1 Million 0.09% of portfolio	6,896	Q4 2024 New
KURA Kura Oncology, Inc.	$555M	$94.3 Million 0.09% of portfolio	10,825	Q4 2024 New
TGTX Tg Therapeutics, Inc.	$4.5B	$93.5 Million 0.09% of portfolio	3,106	Q4 2024 New
MRNA Moderna, Inc.	$13.2B	$88.3 Million 0.09% of portfolio	2,123	Q4 2024 New
VRDN Viridian Therapeutics, Inc.\De	$626M	$85.1 Million 0.08% of portfolio	4,438	Q4 2024 New
RCKT Rocket Pharmaceuticals, Inc.	$826M	$74.9 Million 0.07% of portfolio	5,958	Q4 2024 New
JANX Janux Therapeutics, Inc.	$1.56B	$74.5 Million 0.07% of portfolio	1,391	Q4 2024 New
REGN Regeneron Pharmaceuticals, Inc.	$73.5B	$73.4 Million 0.07% of portfolio	103	Q4 2024 New
EXEL Exelixis, Inc.	$11.3B	$69.9 Million 0.07% of portfolio	2,098	Q4 2024 New
APLS Apellis Pharmaceuticals, Inc.	$3.12B	$62.4 Million 0.06% of portfolio	1,957	Q4 2024 New
EWTX Edgewise Therapeutics, Inc.	$1.68B	$54.8 Million 0.05% of portfolio	2,053	Q4 2024 New
ADMA Adma Biologics, Inc.	$3.16B	$51.2 Million 0.05% of portfolio	2,983	Q4 2024 New
ROIV Roivant Sciences Ltd.	$7.52B	$51.2 Million 0.05% of portfolio	4,324	Q4 2024 New
ARWR Arrowhead Pharmaceuticals, Inc.	$2.23B	$46.3 Million 0.05% of portfolio	2,464	Q4 2024 New
SBTX Silverback Therapeutics, Inc.	$0	$42.5 Million 0.04% of portfolio	4,028	Q4 2024 New
RARE Ultragenyx Pharmaceutical Inc.	$3.1B	$37.8 Million 0.04% of portfolio	899	Q4 2024 New
IDYA Ideaya Biosciences, Inc.	$993M	$37.3 Million 0.04% of portfolio	1,452	Q4 2024 New
ASND Ascendis Pharma A/S	$8.66B	$36.9 Million 0.04% of portfolio	268	Q4 2024 New
KROS Keros Therapeutics, Inc.	$273M	$34.4 Million 0.03% of portfolio	2,175	Q4 2024 New
MDGL Madrigal Pharmaceuticals, Inc.	$5.88B	$32.7 Million 0.03% of portfolio	106	Q4 2024 New
PTCT Ptc Therapeutics, Inc.	$3.61B	$31.6 Million 0.03% of portfolio	701	Q4 2024 New
LEGN Legend Biotech Corp	$6.49B	$31.6 Million 0.03% of portfolio	970	Q4 2024 New
IMVT Immunovant, Inc.	$3.55B	$27.6 Million 0.03% of portfolio	1,116	Q4 2024 New
IBRX Immunity Bio, Inc.	$1.56B	$25.5 Million 0.02% of portfolio	9,946	Q4 2024 New
AGIO Agios Pharmaceuticals, Inc.	$1.86B	$24.9 Million 0.02% of portfolio	759	Q4 2024 New
MIRM Mirum Pharmaceuticals, Inc.	$1.92B	$24.6 Million 0.02% of portfolio	594	Q4 2024 New
PCVX Vaxcyte, Inc.	$4.89B	$24.1 Million 0.02% of portfolio	295	Q4 2024 New
VRTX Vertex Pharmaceuticals Inc	$121B	$23.8 Million 0.02% of portfolio	59	Q4 2024 New
INCY Incyte Corp	$15.6B	$22.6 Million 0.02% of portfolio	327	Q4 2024 New
CYTK Cytokinetics Inc	$4.37B	$21.5 Million 0.02% of portfolio	457	Q4 2024 New
KRYS Krystal Biotech, Inc.	$4.52B	$21.1 Million 0.02% of portfolio	135	Q4 2024 New
ACLX Arcellx, Inc.	$2.84B	$18.3 Million 0.02% of portfolio	239	Q4 2024 New
GMAB Genmab A/S	$14.5B	$18 Million 0.02% of portfolio	861	Q4 2024 New
VCYT Veracyte, Inc.	$3.01B	$17.1 Million 0.02% of portfolio	433	Q4 2024 New
BPMC Blueprint Medicines Corp	$5.62B	$16.7 Million 0.02% of portfolio	192	Q4 2024 New
DYN Dyne Therapeutics, Inc.	$715M	$15.2 Million 0.01% of portfolio	646	Q4 2024 New
AVXL Anavex Life Sciences Corp.	$680M	$11.9 Million 0.01% of portfolio	1,107	Q4 2024 New
DNLI Denali Therapeutics Inc.	$2.98B	$11.4 Million 0.01% of portfolio	560	Q4 2024 New
OMER Omeros Corp	$580M	$9.96 Million 0.01% of portfolio	1,008	Q4 2024 New
LGND Ligand Pharmaceuticals Inc	$2.06B	$9.64 Million 0.01% of portfolio	90	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caitong International Asset Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Caitong International Asset Management Co., LTD with notifications on news.